Document Detail

Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.
MedLine Citation:
PMID:  20700055     Owner:  NLM     Status:  In-Process    
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in Switzerland.
DESIGN: Cross-sectional population-based study of 3238 women and 2846 men aged 35-75.
METHODS: Dyslipidaemia prevalence, treatment and control were defined according to PROCAM guidelines adapted to Switzerland.
RESULTS: About 29% of the overall sample presented with dyslipidaemia, of which 39% were treated and 58% of those treated were controlled. Among the 710 patients with personal history of cardiovascular disease (CVD) and/or diabetes, 632 (89%) presented with dyslipidaemia, of which 278 (44%) and 134 (21%) patients were treated and adequately controlled, respectively. On multivariate analysis, hypolipidaemic drug treatment was positively related with age and body mass index (P for trend <0.001), and negatively related with smoking status (P for trend <0.002), whereas personal history of CVD and/or diabetes had no effect [odds ratio (OR)=1.12, 95% confidence interval (CI): 0.90-1.38]. Adequate control of lipid levels was negatively related with female sex (OR=0.65, 95% CI: 0.45-0.94) and personal history of CVD and/or diabetes (OR=0.42, 95% CI: 0.30-0.59). When personal history of CVD and/or diabetes was replaced by PROCAM risk categories, patients in the highest risk were also less well controlled.
CONCLUSION: In this population-based study, one-third of the participants was dyslipidaemic, but less than half was treated and only one-fifth was adequately controlled. The low treatment and control levels among individuals at high risk for CVD calls for a better application of recommendations regarding personal preventive measures.
Mathieu Firmann; Pedro Marques-Vidal; Fred Paccaud; Vincent Mooser; Nicolas Rodondi; Gérard Waeber; Peter Vollenweider
Related Documents :
15140535 - Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality i...
19119685 - Environmental risk factors for heart disease.
21068345 - Milk and dairy consumption and incidence of cardiovascular diseases and all-cause morta...
12409955 - Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. a compa...
9255745 - Womens attitudes and knowledge about the climacteric period and its treatment. a swedis...
11147235 - Quality of life measures in the miami hiv-1 infected drug abusers cohort: relationship ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  17     ISSN:  1741-8275     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-01-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  682-7     Citation Subset:  IM    
Department of Medicine, Centre for Cardiovascular and Metabolic Research (Cardiomet), University Hospital, University of Lausanne, Lausanne, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  All-cause mortality of patients with dyslipidemia up to 19 years after a multidisciplinary lifestyle...
Next Document:  Assessment of mammographic density before and after first full-term pregnancy.